Healthcare provider profile · identity verified

Peter A Dicorleto, M.D.

Internal Medicine · MURFREESBORO, TN · NPI 1811985815

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	498	127
Lisinopril	Lisinopril	349	84
Omeprazole	Omeprazole	344	88
Amlodipine Besylate	Amlodipine Besylate	318	72
Losartan Potassium	Losartan Potassium	305	79
Levothyroxine Sodium	Levothyroxine Sodium	244	63
Metformin Hcl	Metformin Hcl	241	62
Simvastatin	Simvastatin	222	54
Metoprolol Succinate	Metoprolol Succinate	212	48
Gabapentin	Gabapentin	191	52
Hydrochlorothiazide	Hydrochlorothiazide	171	44
Tamsulosin Hcl	Tamsulosin Hcl	161	43
Furosemide	Furosemide	160	42
Eliquis	Apixaban	153	23
Duloxetine Hcl	Duloxetine Hcl	136	22
Pantoprazole Sodium	Pantoprazole Sodium	136	40
Potassium Chloride	Potassium Chloride	121	29
Donepezil Hcl	Donepezil Hcl	120	21
Meloxicam	Meloxicam	114	35
Allopurinol	Allopurinol	110	27
Escitalopram Oxalate	Escitalopram Oxalate	107	18
Citalopram Hbr	Citalopram Hydrobromide	104	26
Clopidogrel	Clopidogrel Bisulfate	103	21
Rosuvastatin Calcium	Rosuvastatin Calcium	103	23
Alprazolam	Alprazolam	93	20
Glipizide	Glipizide	90	22
Atenolol	Atenolol	87	22
Famotidine	Famotidine	87	23
Alendronate Sodium	Alendronate Sodium	83	20
Prednisone	Prednisone	80	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	15
Carvedilol	Carvedilol	76	15
Trazodone Hcl	Trazodone Hcl	76	20
Glimepiride	Glimepiride	73	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	17
Metoprolol Tartrate	Metoprolol Tartrate	67	19
Baclofen	Baclofen	64	22
Propranolol Hcl	Propranolol Hcl	59	11
Xarelto	Rivaroxaban	59	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	56	21
Pravastatin Sodium	Pravastatin Sodium	55	16
Cefuroxime	Cefuroxime Axetil	54	47
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	36
Fluticasone Propionate	Fluticasone Propionate	54	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	15
Risperidone	Risperidone	52	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	15
Ozempic	Semaglutide	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	13
Celecoxib	Celecoxib	44	suppressed
Mirtazapine	Mirtazapine	44	suppressed
Jardiance	Empagliflozin	43	suppressed
Tramadol Hcl	Tramadol Hcl	42	13
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Clonidine Hcl	Clonidine Hcl	37	suppressed
Metolazone	Metolazone	37	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	20
Lorazepam	Lorazepam	34	suppressed
Finasteride	Finasteride	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Raloxifene Hcl	Raloxifene Hcl	31	suppressed
Ondansetron Odt	Ondansetron	30	16
Lovastatin	Lovastatin	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	15
Meclizine Hcl	Meclizine Hcl	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Primidone	Primidone	26	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Mometasone Furoate	Mometasone Furoate	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	20
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Estradiol	Estradiol	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Carbamazepine	Carbamazepine	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Ramipril	Ramipril	16	suppressed
Temazepam	Temazepam	16	suppressed
Amoxicillin	Amoxicillin	15	12
Creon	Lipase/Protease/Amylase	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Nadolol	Nadolol	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Novolog	Insulin Aspart	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Trimethoprim	Trimethoprim	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Azithromycin	Azithromycin	12	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error